My VisualA  |   Newsletter  |   Partners         Welcome
Technical Articles
Knowledge Base

Link Charts
V5I1206 - Financial Intelligence Units (FIUs)
V5I0806 - Money Laundering: The Exception
V5I0406 - Network Monitoring
V5I0106 - Filing Compliance
V4I0405 - Terrorism Financing
V4I0305 - Telephone Toll Analysis
V4I0205 - Wire Transfers for Alien Smuggling
V4I0105 - Bust-out Schemes
V3I1204 - Structuring Financial Transactions
V3I1104 - Finished Intelligence (Proactive Analysis)
V3I1004 - Exposing Mortgage Fraud
V3I0904 - MIND Lab Integrates Course Data
V3I0804 - Suspicious SAR-MSB Filing Data
V3I0704 - Integrating Multiple Data Sources
V3I0604 - Analyzing Airline Profitability
V3I0504 - Corporate Fraud
V3I0404 - Employee Master File Analysis
V3I0304 - Prescription Fraud Patterns
V3I0204 - Social Network Analysis (SNA)
V3I0104 - Fraud Detection System (FDS)
V2I1203 - Integration with our Digital Information Gateway
V2I1103 - Financial Transactions Investigation
V2I1003 - Compliance Analysis
V2I0903 - Medical Insurance Claims Analysis
V2I0803 - Corporate Fraud Investigation
V2I0703 - Possible Domestic Terrorist Shooting
V2I0603 - Suspicious Activity Report (SAR) Filing
V2I0503 - Detecting Financial Crimes
V2I0403 - "Referential" Data Sources
V2I0303 - Proactive Analyses
V2I0203 - Transactional Activities
V2I0103 - Temporal Grid

White Papers

Frequently Asked Questions


Referenced in our Newsletter Volume 3, Issue 3 - March 2004

Prescription Fraud Patterns
During 2004, losses due to Medicare fraud, according to some industry experts, will exceed $20 billion dollars. Much of this can be attributed to physicians billing and coding fictitious filings, inflated claims, and other types of improper actions. With the new prescription drug benefits recently signed into law as part of the Medicare reform act, the program can expect to see even more types and patterns of fraud and abuse.

The following "observations" are derived from a real-world pharmacy data set where much of the information described prescription-related features. Thus, there were fields for amount dispensed, day's supply, various class descriptors, state payments, gender, and other statuses of the claim. Specifically, the names of the patients and doctors were removed for this discussion and the interpretation of the results is subject to further domain expertise.

The model created for this analysis is shown below. The CLAIM represents the overall transaction and supports all the attributes for the record. For each CLAIM, there is a single RECEIPIENT (e.g., the patient) and a single PROVIDER (e.g., the pharmacy) who filled the prescription.

A proactive query into the database (using Summarize) reveals a RECIPIENT with multiple CLAIMS that supports the same prescription. In this case, the prescriptions were all for Hydrocodone/APAP. Hydrocodone/APAP is a medication for relieving pain - which is used in Vicodin. Hydrocodone is habit forming and has been part of many high-profile drug abuse cases in recent times. In the diagram below, there are 4 prescriptions shown for Hydocodone filled by the RECEIPIENT (shown in the red color) at the same pharmacy location. Looking at the dates of each claim indicates a new prescription was filled each week. Drilling down on the details shows the specifics of each CLAIM including the day's supply - indicating that there may be an abusive situation forming in this case.

Another example found in the database shows commonality for CLAIMS. Sodium Chloride is taken as an intravenous solution used to supply water and electrolytes to the body. Additionally, it can be used to mix/dilute other forms of IV medications. Dexamethasone is considered a form of steroid like Cortisone and is typically used to treat inflammation, joint pains, and even lymphoma. In the following diagram, the RECEIPIENT has filled the same combination of prescriptions 3 times over a 5 day period using the same pharmacy. In this case the frequency of the CLAIMS is suspect because the dates are exact for each type of CLAIM filed.

In this next example, we focus on patterns with larger numbers of prescriptions filled for a single recipient. In the following diagram there are many duplicate CLAIMS made for the same type of prescription. Although this is not unusual for many medications that are taken regularly or have a certain number of refills, it is the details of those reoccurring CLAIMS that raise suspicion in this case. In the example below, the details for the cluster for the drug Premarin (a form of estrogen) shows that there are two CLAIMS made on the same day each for a 30 day supply. The cluster showing Vioxx (used for osteoarthritis) also has two CLAIMS made within 1 week of each other for a 30 day supply. Needless to say, many insurance companies won't cover the cost of the additional or duplicate medications without cause.

In this final example, the RECEIPIENT shown has filed a large number of CLAIMS on the same date. The larger group of CLAIMS, shown in the lower part of this diagram, were all filed on the same day. In fact, there are 12 different prescriptions filled on 05/01 representing over $1000 in co-pay costs. This type of "spike" in CLAIMS processing should be reviewed to determine if there are any abuses occurring in the system. A sample of the types of prescriptions filled is shown below:

  • Ambien is used to treat insomnia
  • Gemfibrozil is used for lowering cholesterol and triglycerides
  • Isosorbide helps prevent chest pain (angina)
  • Norvasc is also prescribed for angina and high blood pressure
  • Prevacid treats heartburn
  • Sustiva is an inhibitor used for HIV treatment
  • Videx EC is a form of HIV medication
  • Zestril is used for treating high blood pressure
  • Zoloft is an antidepressant

  • There were several other types of patterns exposed in this data set, including the utilization of multiple pharmacies to fill orders within a fairly short time frame - which might be indicative of circumventing protections (checks and balances) within a system. Additionally different combinations of prescriptions, frequencies, dosages, dates, locations, and other variables has lead to the discovery of other patterns not shown here.



    If you found this link chart helpful you can subscribe to our newsletter to receive a new link chart each month in your email.